Evidence from both murine and human data indicate that the regulatory pattern and the function of the RBP-J/NFATc1-miR182 network are well conserved, and therefore strengthen the translational implications of this regulatory network in treating diseases associated with bone destruction, such as RA. Here, NFATC1 is linked to rheumatoid arthritis.